IPO/MergerXlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4 17.07.2025 / 07:00 CET/CESTThe filing demonstrates continued momentum ...

Investment/Mergers & Acquisitions17-Jul-2025 / 06:59 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.PRESS ...

PersonnelChange in Siegfried's Executive Committee 17.07.2025 / 06:30 CET/CESTMedia ReleaseZofingen, July 17, 2025Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing ...

VANCOUVER, BC / ACCESS Newswire / July 16, 2025 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a biopharmaceutical company committed to developing innovative treatments for underserved ...

Boyang Wang on Targeting Underfunded Longevity Projects SINGAPORE, SG / ACCESS Newswire / July 16, 2025 / Immortal Dragons, a ...

Dr. Eugene Aversa, DVM is a trusted small animal veterinarian with 24 years of experience PITTSBURGH, PA / ACCESS Newswire / July 16, 2025 / If your dog has been keeping you up at night with constant ...

Insights from Dr. Airica Steed CLEVELAND, OH / ACCESS Newswire / July 16, 2025 / Transformation is exhilarating. It signals progress, innovation, and the promise of a brighter future. Yet, amidst the ...

Mergers & Acquisitions/Strategic Company DecisionGerresheimer AG: Discussions on potential takeover offer ended / 19:08 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the ...

With Expanded Regional Insights, Black Book Research Highlights Emerging Digital Health Trends Across Asia-Pacific KUALA LUMPUR, MY / ACCESS Newswire / July 16, 2025 / Global healthcare luminaries ...

Research published in JAMA Health Forum projects 13-14 excess deaths and over 800 preventable hospitalizations annually per 100,000 people losing Medicaid coverage SAN FRANCISCO, CA / ACCESS Newswire ...

Boise's growing prominence in advanced urologic care was highlighted recently when Dr. Austen Slade welcomed visiting physicians from Stanford University and the University of Washington to observe ...

Sino Biopharmaceutical is acquiring the remaining stake in LaNova Medicines for US $950.9 million to bolster its cancer drug ...